If you or a loved one were diagnosed with cancer after taking Zantac (Ranitidine), you may be entitled to recover compensation from a Zantac cancer lawsuit case or settlement claim.
A team of drug injury lawyers and class action attorneys is investigating potential Zantac lawsuit and settlement cases of individuals who claim to have been diagnosed with cancer after taking Zantac (Ranitidine).
Zantac (known generically as Ranitidine) is an antacid and antihistimine medication used to treat heartburn, stomach ulcers, gastroesophageal reflux disease (GERD) and similiar conditions that cause too much stomach acid. Ranitidine is an H2 (histamine-2) blocker that decreases the amount of acid created in the stomach.
In September of 2019, the FDA issued a statement alerting the public that some ranitidine medicines, including some products known as the brand-name drug Zantac, contained a nitrosamine impurity called N-nitrosodimethylamine or NDMA. Thereafter, on April 1, 2020, the FDA requested that Zantac (ranitidine) be removed from the market.
Previously, Zantac and Ranitidine were the subject of various recalls due to the possible detection of NDMA, which has been called a probable human carcinogen (i.e., a substance that could cause cancer).
Zantac Cancer Lawsuit Cases
Zantac lawsuit and settlement cases potentially being investigated include claims of individuals who took Zantac or ranitidine and suffered serious injuries, side-effects or complications including, among others, the following types of cancers:
- Pancreatic cancer
- Liver cancer
- Esophageal cancer
- Stomach cancer
- Bladder cancer
- Gastric cancer
- Abdominal cancer
- Pancreatic adenocarcinoma
- Hepatocellular carcinoma
- Hepatoma
- Angiosarcoma of the liver
- Urothelial carcinoma
- Transitional cell carcinoma
The Zantac cancer lawsuits filed in federal district courts have been consolidated and/or transferred into a multi-district litigation or MDL, styled In Re Zantac (Ranitidine) Products Liability Litigation, MDL Case No. 2924, U.S. District Court, Southern District of Florida.
Zantac & Ranitidine Brands
Common brands of zantac and ranitidine include, among others:
- Zantac
- Zantac 150
- Acid Reducer
- Zantac 150 Maximum Strength
- Zantac Maximum Strength Cool Mint
- Zantac 75
- Zantac 75 Regular Strength
- Zantac Maximum Strength 150 Cool Mint
- Ranitidine Injection
- Ranitidine Syrup
- Ranitidine Tablets and Capsules
- Zantac Cool Mint
- Zantac Injection
- Wal-Zan 75
- Heartburn Relief
- Acid Control
- Wal-Zan 150
If you or someone you love took Zantac or Ranitidine for heartburn and were diagnosed with cancer, you may be entitled to compensation from a Zantac cancer lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Sandoz, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.